Shares of Polyrizon Ltd. (NASDAQ:PLRZ – Get Free Report) were down 4.9% on Monday . The stock traded as low as $0.7027 and last traded at $0.7243. Approximately 99,157 shares changed hands during trading, a decline of 60% from the average daily volume of 244,834 shares. The stock had previously closed at $0.7618.
Analyst Ratings Changes
PLRZ has been the topic of a number of research analyst reports. Wall Street Zen raised shares of Polyrizon from a “strong sell” rating to a “hold” rating in a research note on Saturday, September 20th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Polyrizon in a report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Polyrizon currently has an average rating of “Sell”.
Read Our Latest Stock Report on PLRZ
Polyrizon Price Performance
Polyrizon Company Profile
Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.
Read More
- Five stocks we like better than Polyrizon
- How to Use the MarketBeat Stock Screener
- onsemi Places a $6 Billion Bet on Its Own Stock
- Consumer Discretionary Stocks Explained
- HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
- 3 Dividend Kings To Consider
- End the Year Strong With These 3 Comeback Champions
Receive News & Ratings for Polyrizon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polyrizon and related companies with MarketBeat.com's FREE daily email newsletter.
